StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by KPOIndustrieson Mar 18, 2020 2:29pm

85 Views

Post# 30822712

RE:Poop

Nailbiter1 wrote: $36.59.
If all the investors who are dumping EXAS came over to SZLS
we would be at .06 cents right now.

Nails and company, I know there is wishful thinking in the drop of competitors. People here are oblivious to the fact that stocks all around are dropping because of the pandemic. The real question is, where will these companies be post self isolation? This is a liquid market right now. SZLS will be lucky to weather this storm over 0.02. That being said, what is the upside potential? What will the company bring to the table to bring this back to life. After the last financials, personally, I am surprised this is sustaining anywhere near 0.03.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario